Prednisolone (Meticortelone) and prednisone (Meticorten), two new synthetic steroids formerly known as metacortandralone and metacortandracin, have recently been recommended as effective in the treatment of rheumatoid arthritis.1We have investigated the anti-rheumatic, anti-inflammatory, metabolic, and hormonal properties of prednisone at the Beth Israel Hospital in New York City from Nov. 15, 1954, to Feb. 15, 1955. Twelve patients with active rheumatoid arthritis (nine females and three males) and one patient each with disseminated lupus erythematosus, active rheumatic carditis, and acute gouty arthritis superimposed on chronic tophaceous gout were studied. They were observed for periods of 34 to 92 days and received a total prednisone dosage of between 440 to 2,025 mg. SELECTION OF PATIENTS Eleven patients with typical symmetrical rheumatoid arthritis of the peripheral joints of 2 to 25 years' duration were chosen; many had been followed by one of us (J. R. D.) for at least 2 years.